PEPTIDERGIC INNERVATION OF GUINEA-PIG BRAIN VESSELS - COMPARISON WITHIMMUNOHISTOCHEMISTRY AND IN-VITRO PHARMACOLOGY IN ROSTRALLY AND CAUDALLY LOCATED ARTERIES
Jp. You et al., PEPTIDERGIC INNERVATION OF GUINEA-PIG BRAIN VESSELS - COMPARISON WITHIMMUNOHISTOCHEMISTRY AND IN-VITRO PHARMACOLOGY IN ROSTRALLY AND CAUDALLY LOCATED ARTERIES, Journal of the autonomic nervous system, 55(3), 1995, pp. 179-188
The peptidergic innervation of the guinea-pig basilar artery and the p
osterior, middle and anterior cerebral arteries were studied by means
of immunohistochemical and image analysis techniques using whole mount
preparations. An in vitro pharmacological study was performed to corr
elate the distribution of peptide-containing nerves and the action of
neuropeptides on vessel segments from the same vascular regions, The o
verall distribution of perivascular nerve fibres was demonstrated usin
g an antiserum to the general neuronal marker protein gene product 9.5
(PGP 9.5) and the percentage immunostained area of total vessel wall
area occupied by PGP-containing nerves, in each of the basilar, poster
ior and middle cerebral arteries, was set at 100% and used to determin
e the relative density of specific populations of autonomic and sensor
y nerve fibres. In all four cerebral arteries, the majority of nerve f
ibres possessed neuropeptide Y (NPY) and tyrosine hydroxylase (TH) imm
unoreactivity, occupying 6.2-13.3% and 5.8-7.5% of the total vessel wa
ll area, respectively. Vasoactive intestinal peptide (VIP), substance
P (SP) and calcitonin-gene-related peptide (CGRP) were detected at low
er densities. The pharmacological study performed on small circular se
gments with an intact endothelium revealed that, in all four cerebral
arteries, NPY was a more potent constrictor than noradrenaline (NA), T
he rank order of potency for relaxant agents was CGRP = SP. VIP > ACh
in the PCA and MCA, and SP = CGRP > VIP > ACh in the BA and ACA, The c
orrelation between immunostained nerve area and the agonist potency su
ggested that the denser the peptidergic nerve-supply, the lower the se
nsitivity to the agonist.